<DOC>
	<DOCNO>NCT03058666</DOCNO>
	<brief_summary>Study test hypothesis aerosolize Infasurf decrease need intubation instillation liquid surfactant airway .</brief_summary>
	<brief_title>Comparison Aerosol Delivery Infasurf Usual Care Spontaneously Breathing RDS Patients</brief_title>
	<detailed_description>Treatment mask . The study objective document aerosolize Infasurf superior `` usual care '' provide patient effective surfactant therapy less need endotracheal intubation instillation surfactant suspension airway . Two cohort recruit : ( ) patient receive surfactant birth develop RDS first hour life ( b ) patient receive instillation surfactant RDS first hour life , extubated , continue RDS .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Calfactant</mesh_term>
	<criteria>RDS Patients 1 . NICU patient , ≥1hour age &lt; 24 hour age . 2 . Clinical diagnosis RDS , without chest Xray data . 3 . Inspired oxygen ≥25 % maintain adequate oxygen saturation . 4 . Not intubated 5 . Requiring : 1. nasal continuous positive airway pressure ( nCPAP ) . 1 . Congenital anomaly limit care option require early surgery . 2 . Cardiopulmonary decompensation . 1. hypotension metabolic acidosis ( base excess &lt; 10 meq/l ) . 2 . Oxygen saturation &lt; 88 % start aerosolization . 3 . PaCO2 ≥ 60 mmHg start aerosolization . 3 . Grade 3 Grade 4 intraventricular hemorrhage cranial ultrasound , know . 4 . Acute hypoxic encephalopathy without seizure .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Hours</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Aerosol</keyword>
	<keyword>surfactant</keyword>
	<keyword>calfactant</keyword>
	<keyword>Infasurf</keyword>
	<keyword>Respiratory Distress Syndrome</keyword>
	<keyword>RDS</keyword>
	<keyword>Premature</keyword>
	<keyword>Neonates</keyword>
</DOC>